Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV
· Real-Time Price · USD
11.84
0.09 (0.77%)
At close: Aug 15, 2025, 3:59 PM
11.85
0.08%
After-hours: Aug 15, 2025, 05:36 PM EDT
Roivant Sciences Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Cash & Equivalents | 2.72B | 1.99B | 1.97B | 5.68B | 6.54B | 6.67B | 1.41B | 1.43B | 1.68B | 1.53B |
Short-Term Investments | 2.17B | 3.16B | 3.43B | n/a | 5.37M | 5.17M | 5.47M | -10.29M | n/a | n/a |
Long-Term Investments | 302.94M | 290.04M | 319.52M | 262.98M | 247.75M | 239.93M | 250.39M | 306.53M | 304.32M | 282.1M |
Other Long-Term Assets | 32.86M | 33.88M | 28.73M | 23.43M | 39.11M | 46.85M | 49.8M | 36.02M | 49.48M | 36.59M |
Receivables | n/a | 143.78M | 22.68M | 82.81M | 63.19M | 54.62M | 39.91M | 39.91M | 37.64M | 29.45M |
Inventory | n/a | n/a | n/a | 34M | 35.25M | 5.24M | 4.91M | 4.22M | 2.76M | n/a |
Other Current Assets | 113.17M | 16.02M | 325.66M | 17.59M | 28.59M | 17.68M | 13M | 13M | 20.54M | 15.87M |
Total Current Assets | 5B | 5.36B | 5.8B | 6B | 6.73B | 6.81B | 1.55B | 1.56B | 1.8B | 1.65B |
Property-Plant & Equipment | 101.08M | 104.46M | 56.65M | 63.15M | 65.95M | 68.75M | 73.11M | 87.9M | 92.34M | 91.93M |
Goodwill & Intangibles | n/a | n/a | n/a | 136.01M | 137.84M | 150.41M | 140.62M | 145.04M | 144.88M | 146.1M |
Total Long-Term Assets | 436.88M | 428.38M | 404.91M | 494.95M | 490.65M | 505.95M | 513.92M | 575.49M | 591.02M | 556.73M |
Total Assets | 5.44B | 5.79B | 6.21B | 6.5B | 7.22B | 7.31B | 2.07B | 2.14B | 2.39B | 2.2B |
Account Payables | 23.69M | 23.71M | 25.13M | 27.74M | 35.23M | 35.23M | 44.12M | 50.03M | 37.83M | 48M |
Deferred Revenue | 1.17M | n/a | 3.41M | 2.66M | 4.17M | 4.7M | 5.8M | 10.57M | 12.44M | 7.8M |
Short-Term Debt | n/a | 9.84M | n/a | 12M | 45.71M | 49M | 44.41M | 44.41M | 40.72M | 49.59M |
Other Current Liabilities | 53.93M | 68.08M | 473.93M | 85.94M | 82.17M | 89.13M | 138.59M | 107.48M | 74.84M | 91.32M |
Total Current Liabilities | 149.41M | 141.48M | 556.25M | 215.04M | 266.76M | 244.9M | 265.55M | 245M | 272.45M | 244.25M |
Long-Term Debt | 90.33M | 90.48M | n/a | 430.59M | 403.34M | 389.44M | 385.07M | 385.07M | 375.51M | 375.12M |
Other Long-Term Liabilities | 10M | 24.41M | 26.55M | 29.34M | 32.8M | 45.12M | 37.48M | 120.62M | 80.58M | 101.52M |
Total Long-Term Liabilities | 100.33M | 114.89M | 69.74M | 386.12M | 507.19M | 483.2M | 474.36M | 557.5M | 509.57M | 531.57M |
Total Liabilities | 249.74M | 256.38M | 625.99M | 601.16M | 773.95M | 728.1M | 739.91M | 802.51M | 782.02M | 775.82M |
Total Debt | 100.17M | 100.31M | 52.71M | 379.06M | 499.75M | 506.58M | 497.98M | 492.63M | 481.4M | 479.64M |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | 116.06M | 460.4M | 395.58M | 671.47M | 576.17M | 727.29M | -4.37B | -4.06B | -3.77B | -3.74B |
Comprehensive Income | 9.44M | 8.06M | -18.04M | -17.95M | -4.08M | -27.78M | -3.07M | -6.61M | -2.62M | -729K |
Shareholders Equity | 4.69B | 5.19B | 5.58B | 5.44B | 5.97B | 6.09B | 948.53M | 910.73M | 1.16B | 955.52M |
Total Investments | 2.47B | 3.45B | 3.75B | 262.98M | 247.75M | 239.93M | 250.39M | 296.24M | 304.32M | 282.1M |